BCAB vs CE · $5.9M cap vs rev $10.28B
Bioatla Inc (BCAB) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BCAB currently screens at market cap $5.9M. CE currently screens at market cap $5.92B.
Not investment advice. Open the BCAB and CE stock pages for the full models.
Not investment advice.